RxDoctor Payments Data

Donna Parsley, DO

Family Medicine · Reynoldsburg, OHNPI 1437192952

Payments from drug & device makers

$712in general payments, 2019–2025

Across 33 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$152
  • Asahi Intecc USA, Inc.$135
  • Exact Sciences$133
  • Novo Nordisk$76
  • GSK$41
  • Abbott$39
  • plus $138 from 7 others

What the payments were for

  • Food & beverage$712100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$712 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$78,465
Medicare patients
132
Services billed
2,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide75$73,169
JanuviaSitagliptin Phosphate41$37,678
EliquisApixaban35$35,677
JardianceEmpagliflozin26$31,719
Tresiba Flextouch U-200Insulin Degludec24$17,801
TradjentaLinagliptin17$12,619
TrulicityDulaglutide11$11,036
DuleraMometasone/Formoterol16$7,818
Methylphenidate ErMethylphenidate Hcl11$4,397
Atorvastatin Calcium309$3,690
Duloxetine Hcl30$2,444
Gabapentin104$2,402
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen109$2,273
Celecoxib32$2,181
Albuterol Sulfate HfaAlbuterol Sulfate64$2,019

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$76$73,16975 claims
MerckJanuvia, Dulera$23$45,49657 claims
Boehringer IngelheimJardiance, Tradjenta$19$44,33843 claims
PfizerEliquis$13$35,67735 claims
Lilly USA, LLCTrulicity$26$11,03611 claims
AbbVieSynthroid$152$99913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Reynoldsburg

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →